Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer
Kazuhiko Shien(Okayama University Hospital), Shinichi Toyooka(Okayama University Hospital)
Cited by 27
Related Papers
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features
|Scientific Reports|2017|60
Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer
|Oncology Letters|2017|28
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
|Oncogenesis|2018|27